Vimovo 500mg/20mg modified-release tablets
BNF presentation 1001010P0BUAABB within chapter Musculoskeletal and Joint Diseases. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
1001010P0BUAABB
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
488
NHS spend (£)
£6,914.11
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 58 |
| December 2024 | 13 |
| November 2024 | 61 |
| October 2024 | 31 |
| August 2024 | 31 |
| July 2024 | 77 |
| May 2024 | 12 |
| July 2021 | 10 |
| June 2021 | 9 |
| December 2020 | 65 |
| November 2020 | 121 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 157 | No data available |
|
New Lyminge Surgery
ODS G82684
|
55 | 91Q - KENT AND MEDWAY ICB |
|
Tardis Surgery
ODS M83096
|
24 | 05G - STAFFORDSHIRE & STOKE-ON-TRENT ICB |
| Unknown pharmacy | 13 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |